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Prevention of renal failure in patients undergoing
thoracoabdominal aortic aneurysm repair
Michael J. Jacobs, MD,a Randolph G. Statius van Eps, MD,b Dick S. de Jong, CCP,b Geert Willem H.
Schurink, MD,a and Bas Mochtar, MD,b Maastricht, The Netherlands
Objective: Renal failure is a potential complication after thoracoabdominal aortic aneurysm (TAAA) repair and is a
significant risk factor for postoperative mortality. We assessed the results of distal aortic perfusion and continuous
volume-controlled and pressure-controlled blood perfusion of the kidneys during TAAA repair in patients with
preoperative normal and impaired renal function.
Methods: Surgical repair of TAAA was performed in 279 consecutive patients (type I, n  90; type II, 117; type III, 42;
type IV, 30). In 195 patients preoperative renal function was normal; however, in 84 patients renal insufficiency was
diagnosed (serum creatinine concentration [SCr], 1.4-2.0 mg/dL, n  46; SCr, 2.0-2.5 mg/dL, n  20; and SCr, >2.5
mg/dL, n  18). Renal perfusion was established with catheters connected to the left-sided heart bypass. Volume flow
was assessed with ultrasound, and pressure channels in the catheters enabled pressure- controlled perfusion of the
kidneys.
Results: Selective renal artery perfusion was achieved in all patients without technical problems or complications. In each
catheter, mean arterial pressure was 69 mm Hg and volume flow was 275 mL/min. During aortic cross-clamping, urine
output was uninterrupted, irrespective of clamp time. Most patients demonstrated limited or moderate increase in SCr
concentration. In 17 patients (6%) SCr doubled, and peaked above 3mg/dL, but returned to baseline levels within several
days. Three patients (1%) required temporary dialysis but were discharged without further need for dialysis. In general,
preoperative renal impairment did not worsen.
Conclusion:Distal aortic and selective renal blood perfusion is an effective measure to protect renal function during TAAA
repair, but only if perfusion is provided with adequate volume and pressure. This technique also averts dialysis in most
patients with preoperative renal failure. ( J Vasc Surg 2004;40:1067-73.)Postoperative renal failure predisposes to adverse out-
come. After coronary artery bypass surgery even mild renal
failure induces increased mortality, prolonged mechanical
ventilation, and higher incidence of dialysis.1 Renal failure
after thoracoabdominal aortic aneurysm (TAAA) repair
increases the risk for early death nearly 10-fold.2 The most
important adjunctive measures that have been developed to
decrease the incidence of renal failure are renal hypother-
mia and renal perfusion with oxygenated blood. The pur-
pose of cold crystalloid renal artery perfusion is to reduce
the metabolic needs of the kidneys, whereas selective blood
perfusion limits the duration of ischemia, averting the
detrimental effects of reperfusion injury.3 Köksoy et al4
demonstrated that selective crystalloid perfusion offers su-
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mothermic blood perfusion. Also, Safi et al5 showed that
blood perfusion of the kidneys does not contribute to renal
protection. In a previous report we demonstrated in a
limited series that selective renal perfusion is only effective if
provided at adequate local arterial pressure.6 This prospec-
tive study describes our extended experience with volume-
controlled and pressure-controlled perfusion in patients
undergoing TAAA repair, both with preoperative normal
and impaired renal function.
PATIENTS AND METHODS
Patients. Between 1995 and 2004 surgical repair of
TAAA was performed in 279 consecutive patients. The
Crawford classification was used to describe the extent of
the aneurysm; 90 were type I, 117 were type II, 42 were
type III, and 30 were type IV. Mean age of 185 male
patients and 94 female patients was 57 years (range, 20-83
years). The cause of the aneurysm was degenerative disease
in 176 patients; chronic, dilating type B dissection in 65
patients; and Marfan disease in 38 patients. Sixteen patients
underwent an emergency procedure because of aortic
rupture.
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nine (SCr) concentration, is summarized in Table I. In 195
patients renal function was normal; however, in 84 patients
renal insufficiency, varying from mild to severe, was diag-
nosed. Preoperative risk factors included hypertension
(62%), chronic obstructive pulmonary disease (32%), dia-
betes (12%), myocardial infarction (24%), and previous
aortic surgery (18%). Preoperative cardiac assessment was
performed in all patients and included echocardiography
and dipiridamole-thallium scanning before and after stress.
In patients with myocardial ischemia, coronary arteriogra-
phy was performed, followed if necessary with percutane-
ous transluminal coronary angioplasty (n  8) or coronary
artery bypass grafting (n  5).
TAAA protocol. In all patients the same protocol was
used. Intubation is performed with a double-lumen endo-
tracheal tube or a selective left main bronchial blocker,
enabling collapse of the left lung. Cerebrospinal fluid pres-
sure is assessed with an intrathecal catheter and monitored
during the procedure and in the intensive care unit until the
third postoperative day. Cerebrospinal fluid is allowed to
drain spontaneously if pressure increases to greater than 10
mm Hg.
Transcranial electrical stimulation is performed to
monitor motor evoked potentials. This technique, which
has been described in detail,7,8 enables intraoperative as-
sessment of spinal cord function and guides the protective
and surgical strategies to prevent paraplegia. Adequate
anesthetic technique is essential because complete neuro-
muscular blockade is not compatible with myogenic motor
evoked potential monitoring. Induction of anesthesia is
achieved with etomidate and sufentanil, and is maintained
with sufentanil and ketamine. Graded muscle relaxation is
maintained with vecuronium and guided with a closed-
loop feedback system, with application of a relaxograph
neuromuscular transmission monitor.
Surgical protocol. Patients are placed in a left helical
position on a vacuum beanbag. A thoracolaparotomy
through the sixth intercostal space (eighth intercostals
space in patients with type IV aneurysms) is followed by
limited incision of the anterior diaphragm and opening of
the crus. A loop around the diaphragm enables movement
of the diaphragm and exposes the aorta without the neces-
Table I. Preoperative renal function and number of








 1.4 195 (70%) 0
1.4-2.0 46 (17%) 0
2.0-2.5 20 (7%) 1
2.5-3.0 14 (5%) 1
 3.0 4 (1%) 1
Total 279 (100%) 3 (1%)sity of completely transecting the muscle. After limitedheparinization (50 U/kg), distal aortic perfusion is estab-
lished with cannulation of the left pulmonary vein and the
femoral artery with a centrifugal pump. An arterial line is
inserted in the contralateral femoral artery. In patients who
have previously undergone infrarenal aortic repair the graft,
rather than the femoral artery, is used for arterial cannula-
tion. In most type IV aneurysms a partial extracorporeal
bypass graft is implanted with femoral vein–femoral artery
cannulation because of the lower thoracic access.
In general, the aortic reconstruction is performed from
proximal to distal. However, in extensive (chronic) type B
aortic dissection involving the iliac arteries we prefer to
reverse the surgical direction because of the unpredictable
changes in organ perfusion with retrograde flow through
the dissected iliac arteries and aorta. This is feasible if the
infrarenal aorta is not aneurysmal or sequential infrarenal
clamping of the aneurysmal aorta is possible. In these cases
an aortobiiliac prosthesis is implanted first. Then the main
body of the graft is cross-clamped and cannulated. After
starting the left-sided heart bypass, aortic reconstruction is
begun with the abdominal phase, followed by the thoracic
segments. This sequential approach is possible only if the
shape of the aneurysm allows sequential clamping. Using
the left-sided heart bypass, body temperature can be de-
creased to 32°C to 33°C, and after the aortic reconstruc-
tion the patient is rewarmed.
The principles of selective organ perfusion are pre-
sented schematically in Figs 1 through 3. A 4-branched
tubing system is connected to the left-sided heart bypass
(Fig 1), and 4 catheters with balloon-inflatable tips are used
for perfusion of the celiac axis, superior mesenteric artery,
and both renal arteries (Fig 2). The celiac axis and superior
mesenteric artery are cannulated with 14F catheters, and
the renal arteries, depending on their diameter, are cannu-
lated with 9F to 12F catheters (Medtronic DLP). These
perfusion catheters are equipped with pressure channels,
enabling pressure-controlled selective perfusion. Further-
more, in each catheter volume flow was assessed with
ultrasound flow meters (Transonic). In type I and II
TAAAs the proximal cross-clamp position depends on the
extent of the aneurysm. In any case, the aorta is completely
freed from the esophagus after transection of the ductus
arteriosus. If the shape of the thoracic descending aorta
allows sequential cross-clamping, these positions are pre-
pared.
In the abdomen the aorta is approached through the
left retrocolic or retrorenal access. After the left kidney is
tilted the left renal artery is dissected and secured with a
vessel loop. After proximal cross-clamping, transection of
the aorta, and completion of the anastomosis, distal aortic
perfusion is maintained at a mean pressure1 of 60 mm Hg
or greater. Based on urine output (15 mL per 15 min-
utes) and the amplitude of motor evoked potentials, this
arterial pressure is increased, if necessary. Intercostal arter-
ies between T8 and T12 are routinely reattached. After
abdominal aortotomy, all 4 selective perfusion catheters are
installed. In general, the celiac axis, superior mesenteric
artery, and right renal artery are reattached as a single unit
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perfusion catheters are removed, indicating that ischemic
time is limited to the time of insertion and removal of the
catheters and applying the closing stitches to the aorta. In
most cases the left renal artery is treated with a selective
graft. The selective perfusion catheter is inserted in the
renal artery through the separate 6-mm or 8-mm polyester
graft, offering continuous blood perfusion during creation
of the end-to-end anastomosis (Fig 3). After completion of
the anastomosis, the tip of the catheter is withdrawn into
the graft, and perfusion is continued until reimplantation in
the aortic tube graft is accomplished.
If there is concomitant disease (aneurysm, ostial steno-
sis, occlusion) of the visceral or renal arteries or a sludgy
aortic wall, separate grafts are inserted, with the same
continuous blood perfusion. The same technique is used,
creating the distal end-to-end anastomosis between the
graft and the visceral artery first, with the perfusion catheter
in the graft and the tip in the target artery. Then the
graft-to-graft anastomosis is performed, and the selective
catheter is removed. In patients with Marfan syndrome,
aortic tissue is excluded as much as possible, which requires
individual grafts to the visceral and renal arteries. To avoid
Fig 1. Schematic setup of left-sided heart bypass and selective
organ perfusion catheters. Proximal aortic cross-clamping and
distal aortic perfusion; selective perfusion catheters are not func-
tional yet.kinking, these grafts are cut in sufficient length to allow aloop-shaped position and anastomosis in the aortic tube
graft. Urine output is the main parameter that dictates the
level of mean arterial pressure in both renal arteries.
Definitions. Postoperative renal dysfunction was eval-
uated according to the score proposed by Kashyap et al2:
1. SCr elevation less than 50% above baseline.
2. SCr elevation 50% to 100% above baseline.
3. Doubling of SCr level, but peak less than 3.0 mg/dL.
4. Acute renal failure, that is, doubling of SCr level and SCr
level greater than 3.0 mg/dL.
5. Acute renal failure necessitating dialysis.
RESULTS
Clinical outcome. There were no intraoperative
deaths, and in-hospital mortality was 8.6% (24 of 279
patients). Three of the 24 patients who died were operated
on in an emergency setting. Nine patients had a lethal
myocardial infarction, 8 died of respiratory failure and
Fig 2. After completion of the proximal anastomosis and opening
of the abdominal aorta, selective perfusion catheters are inserted in
mesenteric and renal arteries.sepsis, 3 died of stroke, and 4 died of multiple organ failure.
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or persistent atelectasis or required prolonged ventilatory
support. Visceral organ ischemia was not encountered.
Overall neurologic deficit, including early (n 1), delayed
(n  3), or temporary (n  2) paraplegia, developed in
2.1% of patients and was permanent in 1.4%.
Renal outcome. Implantation of left-sided heart by-
pass and selective perfusion was achieved in all patients. In
total, 203 separate grafts to the renal arteries were im-
planted, 22 to the celiac axis and 31 to the superior mes-
enteric artery. Of the 203 renal grafts, 181 were anasto-
mosed to the left renal artery and 22 to the right renal
artery. In 15% of patients ostial disease of the renal arteries
was treated with endarterectomy or segmental resection.
During surgery and cross-clamping, urine output was un-
interrupted in all patients, irrespective of cross-clamp time.
Mean cross-clamp time was 98  14 minutes, includ-
ing clamp time of the abdominal phase of the reconstruc-
Fig 3. Reattachment of celiac axis, superior mesenteric artery,
and right renal artery in aortic tube graft. Selective graft to the left
renal artery is constructed under continuous blood perfusion.tion (76 8 minutes). The latter comprised installment ofthe selective catheters, reattachment of the visceral and
renal arteries, separate grafting, distal anastomosis, and
reattachment of lumbar arteries, if necessary, guided by
motor evoked potentials.
Mean total extracorporeal perfusion time was 138 14
minutes. Mean selective perfusion time to the celiac axis
was 58  4 minutes, to the superior mesenteric artery was
59  6 minutes, to the right renal artery was 59  5
minutes, and to the left renal artery was 90  10 minutes.
Organ ischemic time was limited to the time required for
abdominal aortotomy and insertion of the 4 perfusion
catheters. Mean duration was 4  2 minutes.
Volume flow to the visceral and renal arteries varied
substantially. The minimal volume flow to the kidneys was
80 mL/min with the catheter in the renal artery; however,
after selective grafting and positioning the balloon tip of
the catheter in the graft this volume flow could be raised to
500 mL/min. Mean volume flow per catheter for the renal
arteries was 275 mL/min, and for the visceral arteries was
320 mL/min. Intrarenal mean arterial pressure varied be-
tween 60 and 112 mm Hg, depending on urine output.
Increasing arterial pressure in the renal catheters could only
be achieved by diminishing flow and pressure to the femo-
ral artery or the visceral arteries. Continuous assessment of
renal artery perfusion pressures related to urine output was
a dynamic process in which repeated adjustments were
necessary to maintain adequate renal function.
Mean SCr levels for the entire group of patients before
and after the procedure are shown in Table II, and indicate
slightly elevated SCr at the first postoperative day; further
increase to the peak level, usually at day 5; and gradual
return to baseline levels. The incidence and degree of renal
function and dysfuntion are summarized in Table III. Most
patients exhibited limited or moderate increase in SCr
concentration. In 17 patients (6%), 15 of whom had pre-
operative renal insufficiency, SCr concentration doubled
and peaked above 3 mg/dL. Within several days these
levels returned to baseline, and dialysis was not necessary.
Three patients (1%) required temporary dialysis but were
discharged without further need for dialysis. In 2 of these
patients preoperative SCr concentration between 2.5 and
3.0 mg/dL, and in 1 patient SCr concentration was greater
than 3 mg/dL. These outcomes indicate that most patients
with severe preoperative renal insufficiency could be pro-
tected by selective perfusion, and dialysis was prevented. In
12 patients with SCr levels higher than 1.4 mg/dL, final
postoperative SCr level was lower than baseline, most prob-
Table II. Mean serum creatinine levels (mg/dL) for the
whole group of patients before and after surgery
Preoperative 1.3  0.4
Day 1 1.6  0.8
Day 2 2.0  1.2
Peak 2.4  1.4
Discharge 1.4 0.9ably because of relief of ostial stenosis in these patients.
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Kidney protection during thoracoabdominal aortic op-
erations has been the subject of clinical research for several
decades. Fifteen years ago Svensson et al9 demonstrated
that use of neither pump bypass, atriorenal bypass, nor cold
Ringer’s lactate solution could prevent the complication of
acute renal failure. Alterations and improvements in these
techniques have reduced the incidence of postoperative
renal failure; however, the problem is not yet solved. Basi-
cally, 2 protective measures have proved their clinical value:
cold crystalloid and normothermic blood perfusion. Nor-
mothermic blood perfusion is protective as part of distal
aortic perfusion. However, from the moment the abdomi-
nal aortic segment of the TAAA is opened, selective perfu-
sion seems to fail in maintaining adequate kidney function.5
Köksoy et al4 prospectively compared these 2 methods of
selective renal perfusion, cold crystalloid perfusion versus
normothermic blood perfusion. The incidence of acute
renal dysfunction was significantly higher in the blood
perfusion group compared with the cold crystalloid perfu-
sion group. Multivariate analysis confirmed that the use of
cold crystalloid perfusion was independently protective
against acute renal dysfunction.
The protective capacity of hypothermia has been exten-
sively investigated and proved in kidney transplantation
research. Ex vivo cooling of the kidney before transplanta-
tion provides excellent results, even in non–heart beating–
donor kidneys.10 A limitation of in situ cooling is the
difficulty in lowering core parenchymal temperature to the
targeted 15°C to 20°C because of the risk of lowering the
body temperature and fluid overload. Köksoy et al4 clearly
illustrated this problem, in that kidney temperature could
be reduced to 15°C in fewer than a third of patients. In a
recent clinical series using the cold perfusion technique
only, renal failure was encountered in 13.5% of patients
undergoing TAAA repair.11 Renal failure consisted of need
for dialysis (4.8%), postoperative SCr levels of 3.0 mg/dL
or greater, or doubling of baseline creatinine concentration
in patients with baseline SCr level at least 1.8 mg/dL.
Accepting that cold crystalloid perfusion offers ade-
quate renal protection, it remains mysterious that selective
blood perfusion as the most logical physiologic solution
does not maintain kidney integrity. We are convinced that
the answer to this is determined only by the degree of
arterial pressure in the kidney. As shown in our preliminary
series,6 the present study confirms that selective, normo-
thermic blood perfusion provides renal protection during
TAAA repair, even in patients with moderate and severe
preoperative renal insufficiency. Because the kidneys are
pressure-dependent organs, renal protection can only be
achieved under adequate pressurized perfusion. During
selective perfusion we continuously assess mean arterial
pressure in both kidneys, and in most patients sufficient
arterial pressure could be acquired only by increasing vol-
ume flow to 200 to 400 mL/min per renal catheter by
reducing flow through the femoral artery cannula or one of
the visceral arterial catheters. In our experience, the sum ofceliac and superior mesenteric artery volume flow substan-
tially exceeded the sum of volume flow to both kidneys.
Because of the lower peripheral resistance in the visceral
vascular bed, the celiac and superior mesenteric artery
catheters consume more than both renal arteries do. Not
assessing pressure and volume flow in each perfusion cath-
eter therefore introduces the risk for uncertainty as to
whether the kidneys receive enough blood to be protected
and survive the cross-clamp time. Indeed, Köksoy et al4
provided only 400 mL/min in total to the celiac axis,
superior mesenteric artery, and both renal arteries, and did
not assess individual perfusion rate to each vessel. On the
basis of our experience, the kidneys will not receive enough
flow and arterial pressure under these conditions.
Applying the strict criteria of the renal dysfunction
score, we found that half of the patients had stable SCr
levels after surgery, irrespective of the extent of the aneu-
rysm or cross-clamp times. Another 35% of patients had
50% to 100% maximal elevation; 8% had doubled SCr
concentration; and renal failure developed in 7%, of whom
1% required temporary dialysis. At discharge, no patient
was receiving dialysis, and 3 patients (1%) had SCr levels
higher than 3 mg/dL. It must be emphasized that moder-
ate and severe preoperative renal failure existed in 30% of
patients and that the 3 patients with high SCr levels at
discharge had renal insufficiency before the procedure.
These results indicate that volume flow and pressure-
controlled selective blood perfusion of the kidneys during
TAAA repair not only protects normal functioning kidneys
but also averts permanent dialysis in most patients with
preoperative renal failure.
How can renal protection be further improved? One
solution could be to cool the blood perfused through the
selective catheters, as proposed by Köksoy et al.4 This
would combine adequate tissue oxygenation12 and cold
protection. Another issue addresses the principle of pulsa-
tile versus nonpulsatile flow. Although extensive research
has not proved specific differences between the 2 methods,
it is obvious that nonpulsatile distal aortic and selective
organ perfusion is nonphysiologic, altering local autoregu-
Table III. Postoperative renal function according to
renal dysfunction score: number of patients per category
with levels at peak and discharge
At peak level At discharge
1. Creatinine elevation  50%
above baseline
139 (50%) 238 (85%)
2. Creatinine elevation 50%-100%
above baseline
98 (35%) 28 (10%)
3. Doubling but peak  3.0 mg/dL 22 (8%) 10 (4%)
4. Acute renal failure: double, peak
 3.0 mg/dl
17 (6%) 3 (1%)
5. Acute renal failure: (temporary)
dialysis
3 (1%) 0 (0%)
Total 279 (100%) 279 (100%)lation and many neuroendocrine responses that affect the
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yet be mimicked by our artificial techniques.
Finally, assessment of the efficacy of protective mea-
sures should also be improved, because urine output and
SCr levels are rather primitive parameters to use to deter-
mine renal injury. At present, biomarkers are available to
investigate the function of the glomerulus, proximal tu-
bule, thick ascending limb, and distal connecting nephron.
Future studies should include these parameters that repre-
sent renal function.
In conclusion, in addition to distal aortic perfusion,
volume-controlled and pressure-controlled selective renal
blood perfusion protects renal function during TAAA re-
pair. This technique also prevents dialysis in most patients
with preoperative renal failure.
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Dr Tam Huynh (Houston, Tex). We recently reviewed our
own incidence of renal failure and that of others with regard to the
various effects of renal protection strategies. As Dr Jacobs and
coauthors pointed out in their introduction, there has been no
effective single method of renal protection during TAAA repair,
and the reported rate of renal failure has been between 5% and 40%.
The most common forms of kidney protection have been
assembled from results of small studies, anecdotal information, and
personal experience. At our institution we have examined a succes-
sion of methods for renal production, beginning with distal aortic
perfusion, followed by warm blood distal perfusion, antegrade cold
blood distal perfusion, and retrograde cold blood perfusion, and
perioperative use of fenoldopam. In our experience, use of these
various renal protection methods has produced mixed results
because many factors cause renal failure, including but not limited
to ischemia and embolization. Distal reperfusion emerged as pro-
tective, but only for aortic repair that does not involve the renal
arteries. And although there is evidence that patients with cold
perfusion have superior survival recovery rates, none of the ad-
juncts used has prevented renal failure. The problem of acute renal
failure cannot be overemphasized.
We have 3 questions for the authors. First, for Crawford I
TAAA, we generally do not need to provide visceral or renal
perfusion, because the distal anastomosis is usually above the renal
arteries by definition. Did the authors use a modified version of
Crawford’s classification, as they reportedly provide visceral and
renal protection for all patients in this series, including the 90
patients with Crawford I disease.
The second question pertains to the actual technique of mea-
suring renal perfusion pressures and flow during TAAA repair. We
agree with the authors that measurement of renal perfusion pres-
sure and flow will enable us to better assess various renal protection
methods. We have sought, but have not found, perfusion catheters
that would permit accurate recording of perfusion pressure. Also,reliable measurements of flow. So what was the standard deviation
in your measurements, and did you use any validation tests?
And finally, the authors’ impressive results would be even
more compelling if they could provide an analysis showing the
correlation between optimal renal perfusion, urinary output, and
changes in renal function. What was the amount of urine that the
authors aimed to achieve during aortic cross-clamping?
Dr Michael J. Jacobs. In type I aneurysms, most of the time,
as you indicated, the anastomosis is just sort of beveled above the
renal arteries, but cross-clamping is still required, and especially in
patients with preoperative renal failure we just put these selective
catheters in, which takes 1 or 2 minutes.
Relating to the question about the pressure catheters with
which you can measure the pressure, they are available, and are
used in cardiac surgery. Inasmuch as they are just on the market,
it’s not a big problem. And the volume flow is assessed with
transducers, which are on the market as well, and really are reliable.
Even so, the perfusionist can tell you that if there is a kink in the
perfusion catheter the pressure drops immediately, and can warn us
if it occurs.
And the last question is in regard to the sensitivity and the
correlation between urine output and what we are actually
doing during the procedure. I agree that these are simple,
parameters, maybe too simple, which means urine output and
assessing serum creatinine. That is not really scientific. But there
are biologic markers now on the market, and we are now
including them in our protocol to show in a more scientific way
what we are doing.
Dr Lars Svensson (Cleveland, Ohio). Back in 1988 at the
Southern Vascular Association meeting we reported on 1500
patients in whom we looked at cold perfusion versus blood
perfusion and found no difference. But we found in patients
with renal disease and stenoses, and we had 271 such patients,
that their blood perfusion did protect the patients. I wonder,
and it wasn’t clear from your data, whether you looked partic-
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stenosis, and what the outcome was in those patients insofar as
rise in creatinine concentration. I realize your incidence of renal
failure was low.
The other question is, if you have a patient with a creatinine
concentration of 3, 4 or 5 mg/dL, do you electively use dialysis
before surgery, inasmuch as there may be some virtue in that?
Dr Jacobs. To answer the first question, all patients in our
analysis were mixed, including patients with renal artery stenosis
with normal and with impaired renal function. The message of
TAA repair. It now seems clear that these data reflect inadequatethis presentation, I would say, is that if you perform selective
perfusion it doesn’t make sense to do it without pressure
measurement. Because if you put the 4 catheters in the 4
arteries, the superior mesenteric and celiac access will steal 80%
to 90% of the blood flow to the visceral organs, and you end up
with maybe 50 mL/min to each kidney, and they just cannot
accept that.
With regard to the second question, in patients with severe
renal impairment before the procedure we do not use dialysis
before the operation.INVITED COMMENTARYRichard P. Cambria, MD
Postoperative acute renal failure (ARF) has traditionally been
an important factor in the overall morbidity of thoracoabdominal
aneurysm repair (TAA). There is consensus that when ARF occurs
in this setting overall mortality increases significantly. In our expe-
rience, ARF after TAA increased mortality nearly 7-fold! In addi-
tion, most series that specifically examine the risk for ARF find that
patients with antecedent renal dysfunction are at significantly
higher risk. Thus assessment of renal function and the potential for
correction of concomitant renovascular disease, present in as many
as 40% of patients with TAA, figures prominently in clinical and
intraoperative decision-making.
Jacobs et al1 herein report their technique for selective pres-
sure and flow volume–controlled renal and visceral perfusion for
specific organ protection during TAA repair. The results achieved
are enviable; overall, 7% of their patients sustained clinically signif-
icant ARF with only a 1% (all temporary) rate of dialysis. By way of
historical perspective, the corresponding respective figures in
Crawford’s large series of 1500 patients with TAA were 18% and
9%!2 Recognizing the variant criteria for defining ARF after TAA
repair and that many patients will have a degree of non-oliguric,
self-limited ARF, the authors have categorized postoperative renal
function according to a scheme we previously reported (see their
reference 2). There is striking concordance with their overall data
and those in our report, indicating that regional hypothermic renal
artery perfusion, which has been our preferred approach, remains a
valid protective adjunct. Furthermore, the authors’ data provide an
explanation for the apparent paradoxic, negative effect of warm
blood renal catheter perfusion reported in several large series ofpressure or volume control of such perfusion, rather than an
inherent deficiency of the technique itself. Finally, it is worth
mention that all of the aforementioned protective adjuncts are
directed at limiting the degree and duration of renal ischemia.
Other considerations, such as avoiding atheroembolism, an ag-
gressive posture toward correction of concomitant renovascular
lesions, and precision in the renovascular reconstructive compo-
nents of TAA repair, are important considerations in the preven-
tion of ARF.
The ARF data of Jacobs and colleagues are a lofty benchmark
in TAA surgery. Overall mortality in their patients was 8.6%, nearly
identical to our own and that of other major series. I believe their
method provides for optimal renal protection and thus should be
considered seriously for application in that subset of patients at
particular risk for ARF (ie, those with abnormal renal function). By
extension, antecedent renal dysfunction is a variable that could
sway an overall operative strategy toward a distal perfusion and
selective visceral and renal perfusion technique for surgeons and
patients when such might not otherwise be used. This report will
likely influence the practice of those involved in TAA repair.
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